Zimmer Biomet Holdings, Inc. (ZBH) stock
ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)
Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%
Zimmer Biomet ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Zimmer Biomet's ebitda for the twelve months ending Jun 30, 2026 was $2.31B, up 0.5% year over year. For fiscal 2025 it was $2.19B, down 3.9% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $2.28B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.19B | -3.9% |
| FY2024 | Dec 31, 2024 | $2.28B | +2.4% |
| FY2023 | Dec 31, 2023 | $2.23B | +37.4% |
| FY2022 | Dec 31, 2022 | $1.62B | -9.7% |
| FY2021 | Dec 31, 2021 | $1.80B | +83.2% |
| FY2020 | Dec 31, 2020 | $981.50M | -54.2% |
| FY2019 | Dec 31, 2019 | $2.14B | +99.5% |
| FY2018 | Dec 31, 2018 | $1.07B | -42.3% |
| FY2017 | Dec 31, 2017 | $1.86B | +0.1% |
| FY2016 | Dec 31, 2016 | $1.86B | +57.7% |
| FY2015 | Dec 31, 2015 | $1.18B | -16.5% |
| FY2014 | Dec 31, 2014 | $1.41B | -1.0% |
| FY2013 | Dec 31, 2013 | $1.43B | +1.2% |
| FY2012 | Dec 31, 2012 | $1.41B | +1.9% |
| FY2011 | Dec 31, 2011 | $1.38B | +10.1% |
| FY2010 | Dec 31, 2010 | $1.26B | -7.3% |
| FY2009 | Dec 31, 2009 | $1.36B | -0.7% |
| FY2008 | Dec 31, 2008 | $1.37B | +0.6% |
| FY2007 | Dec 31, 2007 | $1.36B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $596.90M | +4.4% |
| Q1 FY2026 | Mar 31, 2026 | $643.20M | +17.7% |
| Q4 FY2025 | Dec 31, 2025 | $438.50M | -32.8% |
| Q3 FY2025 | Sep 30, 2025 | $634.90M | +19.7% |
| Q2 FY2025 | Jun 30, 2025 | $571.80M | -3.8% |
| Q1 FY2025 | Mar 31, 2025 | $546.70M | +8.4% |
| Q4 FY2024 | Dec 31, 2024 | $652.60M | +9.6% |
| Q3 FY2024 | Sep 30, 2024 | $530.40M | +4.5% |
| Q2 FY2024 | Jun 30, 2024 | $594.60M | +4.8% |
| Q1 FY2024 | Mar 31, 2024 | $504.50M | -9.8% |
| Q4 FY2023 | Dec 31, 2023 | $595.40M | +197.4% |
| Q3 FY2023 | Sep 30, 2023 | $507.80M | +6.5% |
| Q2 FY2023 | Jun 30, 2023 | $567.10M | +10.4% |
| Q1 FY2023 | Mar 31, 2023 | $559.10M | +29.4% |
| Q4 FY2022 | Dec 31, 2022 | $200.20M | -45.4% |
| Q3 FY2022 | Sep 30, 2022 | $476.70M | +0.1% |
| Q2 FY2022 | Jun 30, 2022 | $513.60M | +11.5% |
| Q1 FY2022 | Mar 31, 2022 | $432.20M | -12.6% |
| Q4 FY2021 | Dec 31, 2021 | $367.00M | -32.4% |
| Q3 FY2021 | Sep 30, 2021 | $476.00M | -14.7% |
| Q2 FY2021 | Jun 30, 2021 | $460.60M | +448.3% |
| Q1 FY2021 | Mar 31, 2021 | $494.40M | – |
| Q4 FY2020 | Dec 31, 2020 | $542.70M | -8.1% |
| Q3 FY2020 | Sep 30, 2020 | $557.80M | +12.2% |
| Q2 FY2020 | Jun 30, 2020 | $84.00M | -81.6% |
| Q1 FY2020 | Mar 31, 2020 | -$203.00M | -134.0% |
| Q4 FY2019 | Dec 31, 2019 | $590.70M | – |
| Q3 FY2019 | Sep 30, 2019 | $497.30M | +2.8% |
| Q2 FY2019 | Jun 30, 2019 | $457.70M | -17.9% |
| Q1 FY2019 | Mar 31, 2019 | $597.90M | +5.2% |
| Q4 FY2018 | Dec 31, 2018 | -$535.70M | -338.7% |
| Q3 FY2018 | Sep 30, 2018 | $483.90M | +1.3% |
| Q2 FY2018 | Jun 30, 2018 | $557.60M | +2.5% |
| Q1 FY2018 | Mar 31, 2018 | $568.50M | -7.7% |
| Q4 FY2017 | Dec 31, 2017 | $224.40M | -47.9% |
| Q3 FY2017 | Sep 30, 2017 | $477.70M | -1.2% |
| Q2 FY2017 | Jun 30, 2017 | $544.20M | – |
| Q1 FY2017 | Mar 31, 2017 | $615.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $430.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $483.60M | – |
See a number that looks wrong?